Elanco Animal Health (ELAN) - Total Liabilities
Based on the latest financial reports, Elanco Animal Health (ELAN) has total liabilities worth $6.97 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Elanco Animal Health's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Elanco Animal Health - Total Liabilities Trend (2016–2025)
This chart illustrates how Elanco Animal Health's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Elanco Animal Health.
Elanco Animal Health Competitors by Total Liabilities
The table below lists competitors of Elanco Animal Health ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Covestro AG
XETRA:1COV
|
Germany | €7.11 Billion |
|
Grupo Cibest S.A.
NYSE:CIB
|
USA | $351.53 Trillion |
|
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM
|
USA | $1.92 Billion |
|
WOORI FIN. GRP SP.ADR/3
F:2WGA
|
Germany | €563.60 Trillion |
|
TFI International Inc
TO:TFII
|
Canada | CA$4.76 Billion |
|
CSPC PHARMACEUT.GR. ADR4
F:CVGU
|
Germany | €12.15 Billion |
|
BIM Birlesik Magazalar AS
IS:BIMAS
|
Turkey | TL207.51 Billion |
|
REXEL S.A. ADR EO 5
F:E7V0
|
Germany | €8.96 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Elanco Animal Health's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Elanco Animal Health balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Elanco Animal Health's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Elanco Animal Health (2016–2025)
The table below shows the annual total liabilities of Elanco Animal Health from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $6.81 Billion | +4.50% |
| 2024-12-31 | $6.52 Billion | -19.92% |
| 2023-12-31 | $8.14 Billion | -0.77% |
| 2022-12-31 | $8.20 Billion | -8.56% |
| 2021-12-31 | $8.97 Billion | -2.68% |
| 2020-12-31 | $9.22 Billion | +168.02% |
| 2019-12-31 | $3.44 Billion | -8.52% |
| 2018-12-31 | $3.76 Billion | +227.03% |
| 2017-12-31 | $1.15 Billion | +7.25% |
| 2016-12-31 | $1.07 Billion | -- |
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide … Read more